Info
13F
Schedule 13D
Ownership

Adage Capital Partners Gp, L.L.C. - Significant Ownership

Signature - Title: /s/ Robert Atchinson - By: Adage Capital Advisors, L.L.C., its Managing Member, By: Robert Atchinson, its Managing Member
Location: Boston, MA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Adage Capital Partners Gp, L.L.C..

Significant Ownership of Adage Capital Partners Gp, L.L.C.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
STTK	Shattuck Labs, Inc.	Common Stock, par value $0.0001 per share	9.79%	$3.74M		4.68M		Adage Capital Management, L.P.	Dec 31, 2024
TCRX	TScan Therapeutics, Inc.	Voting Common Stock, par value $0.0001 per share	7.13%	$5.6M		3.5M		Adage Capital Management, L.P.	Dec 31, 2024
SLNO	SOLENO THERAPEUTICS INC	Common Stock, par value $0.001 per share	6.44%	$204M		2.78M		Adage Capital Management, L.P.	Dec 31, 2024
MREO	Mereo BioPharma Group plc	Ordinary Shares, nominal value 0.003 GBP per share	5.62%	$114M		43.6M		Adage Capital Management, L.P.	Dec 31, 2024
CMPX	Compass Therapeutics, Inc.	Common stock, par value $0.0001 per share	4.36%	$11.6M		5.99M		Adage Capital Management, L.P.	Dec 31, 2024
SOC	Sable Offshore Corp.	Common stock, par value $0.0001 per share	3.59%	$62.7M		3.2M		Adage Capital Management, L.P.	Dec 31, 2024
SYRS	Syros Pharmaceuticals, Inc.	Common stock, par value $0.001 per share	1.98%	$16K		532K		Adage Capital Management, L.P.	Dec 31, 2024
VERU	Veru Inc.	Common Stock, par value $0.01 per share	1.57%	$1.2M		2.3M		Adage Capital Management, L.P.	Dec 31, 2024
NKTX	Nkarta, Inc.	Common stock, par value $0.0001 per share	0%	$0		0		Adage Capital Management, L.P.	Dec 31, 2024

Showing 1 to 9 of 9 entries

Schedules 13D/G Reported by Adage Capital Partners Gp, L.L.C.:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.